Hyphens Pharma out-licenses Cerapro MED Skin Barrier Cream to Louis Widmer for six European markets

SGX Filings

Jan 05

Hyphens Pharma International Limited announced on Jan, 5 2026 that it has signed a licensing, supply and commercialisation agreement granting Louis Widmer SA the rights to market Cerapro MED Skin Barrier Cream in Switzerland, Liechtenstein, Austria, Belgium, Luxembourg and the Netherlands.

Under the agreement, Hyphens Pharma will receive an undisclosed upfront fee and customary sales-based royalties. The two companies aim to launch the pH-lowering cream in the six European markets in 2026.

Cerapro MED is a patented, CE-marked medical device formulated to lower skin pH and help restore the skin barrier in patients with atopic dermatitis.

Louis Widmer, a Swiss cosmetics and pharmaceuticals company established in 1960, will promote the product to dermatologists and paediatricians, expanding its Remederm line for dry and atopic skin.

Hyphens Pharma is a Singapore-headquartered specialty pharmaceutical and consumer healthcare group with operations across Southeast Asia.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1116795094"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1116795094\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1116795094?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-05 18:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116795094","market":"sg","top_or_hot":-1,"title":"Hyphens Pharma out-licenses Cerapro MED Skin Barrier Cream to Louis Widmer for six European markets","media":"SGX Filings","content":"<p>Hyphens Pharma International Limited announced on Jan, 5 2026 that it has signed a licensing, supply and commercialisation agreement granting Louis Widmer SA the rights to market Cerapro MED Skin Barrier Cream in Switzerland, Liechtenstein, Austria, Belgium, Luxembourg and the Netherlands.</p>\n<p>Under the agreement, Hyphens Pharma will receive an undisclosed upfront fee and customary sales-based royalties. The two companies aim to launch the pH-lowering cream in the six European markets in 2026.</p>\n<p>Cerapro MED is a patented, CE-marked medical device formulated to lower skin pH and help restore the skin barrier in patients with atopic dermatitis.</p>\n<p>Louis Widmer, a Swiss cosmetics and pharmaceuticals company established in 1960, will promote the product to dermatologists and paediatricians, expanding its Remederm line for dry and atopic skin.</p>\n<p>Hyphens Pharma is a Singapore-headquartered specialty pharmaceutical and consumer healthcare group with operations across Southeast Asia.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hyphens Pharma out-licenses Cerapro MED Skin Barrier Cream to Louis Widmer for six European markets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHyphens Pharma out-licenses Cerapro MED Skin Barrier Cream to Louis Widmer for six European markets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-01-05 18:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hyphens Pharma International Limited announced on Jan, 5 2026 that it has signed a licensing, supply and commercialisation agreement granting Louis Widmer SA the rights to market Cerapro MED Skin Barrier Cream in Switzerland, Liechtenstein, Austria, Belgium, Luxembourg and the Netherlands.</p>\n<p>Under the agreement, Hyphens Pharma will receive an undisclosed upfront fee and customary sales-based royalties. The two companies aim to launch the pH-lowering cream in the six European markets in 2026.</p>\n<p>Cerapro MED is a patented, CE-marked medical device formulated to lower skin pH and help restore the skin barrier in patients with atopic dermatitis.</p>\n<p>Louis Widmer, a Swiss cosmetics and pharmaceuticals company established in 1960, will promote the product to dermatologists and paediatricians, expanding its Remederm line for dry and atopic skin.</p>\n<p>Hyphens Pharma is a Singapore-headquartered specialty pharmaceutical and consumer healthcare group with operations across Southeast Asia.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"1J5.SI","symbol_name":"凯帆药剂国际有限公司","start_time":0,"source_url":"","article_id":"1116795094","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116795094","pubTimestamp":1767607659,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"Hyphens Pharma International Limited announced on Jan, 5 2026 that it has signed a licensing, supply and commercialisation agreement granting Louis Widmer SA the rights to market Cerapro MED Skin...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"1J5.SI":"凯帆药剂国际有限公司"},"translate_title":"Hyphens Pharma将Cerapro MED皮肤屏障霜授权给Louis Widmer，进军六个欧洲市场","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"1J5.SI":1},"content_text":"Hyphens Pharma International Limited announced on Jan, 5 2026 that it has signed a licensing, supply and commercialisation agreement granting Louis Widmer SA the rights to market Cerapro MED Skin Barrier Cream in Switzerland, Liechtenstein, Austria, Belgium, Luxembourg and the Netherlands.\nUnder the agreement, Hyphens Pharma will receive an undisclosed upfront fee and customary sales-based royalties. The two companies aim to launch the pH-lowering cream in the six European markets in 2026.\nCerapro MED is a patented, CE-marked medical device formulated to lower skin pH and help restore the skin barrier in patients with atopic dermatitis.\nLouis Widmer, a Swiss cosmetics and pharmaceuticals company established in 1960, will promote the product to dermatologists and paediatricians, expanding its Remederm line for dry and atopic skin.\nHyphens Pharma is a Singapore-headquartered specialty pharmaceutical and consumer healthcare group with operations across Southeast Asia.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}